Kidney Disease News and Research

RSS

New guidelines developed to manage heart failure in children with undiagnosed heart disease

Heart failure in children is an important cause of childhood health problems and death. The Children's Heart Failure Study Group of the Canadian Cardiovascular Society, in collaboration with the Canadian Pediatric Cardiology Association, has developed new guidelines to assist practitioners in primary care and emergency departments to recognize and successfully manage heart failure in children with undiagnosed heart disease and symptoms of possible heart failure. The guidelines are published in the December issue of the Canadian Journal of Cardiology.

12 Dec 2013

Baxter seeks FDA approval of OBI-1 for adults with acquired hemophilia A

Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) to the U.S. Food and Drug Administration (FDA) for the approval of OBI-1, a recombinant antihemophilic porcine sequence factor VIII, in patients with acquired hemophilia A.

From Baxter International Inc. 11 Dec 2013

Dye reduction in diagnostic heart procedures: an interview with Mike McCormick, CEO Osprey Medical

Iodine based contrast media (dye) is radiopaque and is commonly used for diagnostic and interventional heart procedures. It allows physicians to see real time images of the heart vessels and treat any blockages.

3 Dec 2013

PES' ESRD Prevention Program effectively identifies patients with early stage renal disease

Patient Engagement Systems, a nationally recognized leader in developing technology to identify, and monitor individuals with chronic kidney disease, today introduced the Patient Engagement Systems' ESRD Prevention Program which uses proprietary technology including automated physician-patient engagement, analytics, and decision support tools to identify patients with undiagnosed chronic kidney disease and tools to monitor them in order to prevent or delay the progression to ESRD.

3 Dec 2013

Bariatric surgery can potentially reverse type 2 diabetes

Although obesity is a notoriously difficult disease to treat conservatively, there is hope. Board-certified bariatric surgeon Michael Feiz, MD, FACS recommends weight loss surgery as a solution for morbidly obese adults who want to get healthy once and for all.

3 Dec 2013

First Nations adults with diabetes more likely to face risk of end-stage kidney disease

First Nations adults with diabetes have more than double the risk of end-stage kidney disease compared with non-First Nations adults, found a new study in CMAJ (Canadian Medical Association Journal).

3 Dec 2013

Nocturia common in Japanese patients

Results from an outpatient-based study indicate that nocturia is common among Japanese patients, with men, the elderly, and those with hypertension at the greatest risk.

2 Dec 2013

Study highlights unique barriers for African Americans with hypertension

For African-Americans who have hypertension, controlling their high blood pressure is critical to avoid serious complications. However, a history of racial discrimination and/or mistrust in their physicians often causes them to skip taking their necessary medication, finds a new study in the American Journal of Public Health.

27 Nov 2013

African Americans have double the risk of end-stage renal disease compared to white Americans

In the United States, African Americans have approximately twice the risk of end-stage renal disease compared to white Americans, despite a similar prevalence in earlier stages of chronic kidney disease. A large study co-authored by George Washington University researcher Dominic Raj, M.D., identifies factors that mediate differences in the progression of chronic kidney disease between black patients and white patients, as well as among black patients, in order to reduce the excess burden of end-stage renal disease and its complications in black patients.

27 Nov 2013

Researchers receive $2.5M grant to study telephone-based approach to improve diabetes treatment outcomes

More than 25 million Americans have diabetes, yet as many as 60 percent of type 2 diabetes patients do not follow treatment plans prescribed by their healthcare provider and about 50 percent fail to meet treatment recommendations for control of blood glucose levels.

26 Nov 2013

Dysregulation of epigenetic marks may play role in chronic kidney disease, shows study

The research of physician-scientist Katalin Susztak, MD, PhD, associate professor of Medicine in the Renal Electrolyte and Hypertension Division, at the Perelman School of Medicine, University of Pennsylvania, strives to understand the molecular roots and genetic predisposition of chronic kidney disease.

26 Nov 2013

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

Janssen-Cilag International NV announced today that the European Commission has approved INVOKANA (canagliflozin) in the European Union for the treatment of adults with type 2 diabetes mellitus, to improve glycaemic control[1]. Canagliflozin is an oral, once-daily medication, which belongs to a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors.

23 Nov 2013

CKD children with lower socio-economic status less likely to grow to normal height ranges

Even with more prescriptions for growth hormone, children and adolescents with chronic kidney disease were less likely to grow to normal height ranges if they came from lower-income families, according to research funded by the National Institutes of Health. Results from the Chronic Kidney Disease in Children Study are published in the December issue of the American Journal of Kidney Diseases and online today at http://www.ajkd.org.

22 Nov 2013

Scientists at Salk Institute develop novel platform to study kidney diseases

Diseases affecting the kidneys represent a major and unsolved health issue worldwide. The kidneys rarely recover function once they are damaged by disease, highlighting the urgent need for better knowledge of kidney development and physiology.

19 Nov 2013

Grave prognosis for heart patients with treatment-resistant hypertension

Patients with coronary artery disease have a particularly high risk for poor outcomes if they have treatment-resistant hypertension, shows an analysis of the Treating to New Targets trial.

18 Nov 2013

Researchers generate three-dimensional kidney structures from human stem cells

18 Nov 2013

Patients who undergo gastric bypass less likely to have risk of heart attack and stroke

New research from the Cleveland Clinic shows most patients with diabetes and obesity who undergo gastric bypass not only experience remission of their diabetes and lose significant weight, but they also reduce their risk of having a heart attack by 40 percent and their risk for suffering a stroke by 42 percent, over a 10-year time horizon.

16 Nov 2013

MGH investigators identify molecule that plays key role in the breakdown of kidney filter

One of the most devastating side effects of diabetes is kidney failure, and one of the earliest signs of kidney damage is a disruption of the organ's filtering capacity. Diabetes patients who develop kidney failure must go on dialysis, seriously limiting their quality of life and placing them at significantly increased risk of death. The incidence of kidney disease is increasing with rising rates of obesity-associated type 2 diabetes, but very little progress has been made towards protecting the kidney's filter barrier during the past 50 years.

16 Nov 2013

Satellite Healthcare, NKF partner to sponsor free Community Kidney Disease Symposium

Satellite Healthcare, one of the nation's first and leading not-for-profit providers of kidney dialysis services and a major sponsor of kidney research, is proud to announce that it has partnered with the National Kidney Foundation to sponsor NKF's free Community Kidney Disease Symposium this Saturday, November 16th in Stockton, California.

16 Nov 2013

OPKO Health completes patient enrollment in first phase 3 trial of Rayaldy for SHPT treatment

OPKO Health, Inc., has completed patient recruitment in the first phase 3 trial of Rayaldy to treat patients with secondary hyperparathyroidism, stage 3 or 4 chronic kidney disease and vitamin D insufficiency.

16 Nov 2013

Kidney Disease News and Research

New guidelines developed to manage heart failure in children with undiagnosed heart disease

Baxter seeks FDA approval of OBI-1 for adults with acquired hemophilia A

Dye reduction in diagnostic heart procedures: an interview with Mike McCormick, CEO Osprey Medical

PES' ESRD Prevention Program effectively identifies patients with early stage renal disease

Bariatric surgery can potentially reverse type 2 diabetes

First Nations adults with diabetes more likely to face risk of end-stage kidney disease

Nocturia common in Japanese patients

Study highlights unique barriers for African Americans with hypertension

African Americans have double the risk of end-stage renal disease compared to white Americans

Researchers receive $2.5M grant to study telephone-based approach to improve diabetes treatment outcomes

Dysregulation of epigenetic marks may play role in chronic kidney disease, shows study

EC approves INVOKANA (canagliflozin) medication for adults with type 2 diabetes mellitus

CKD children with lower socio-economic status less likely to grow to normal height ranges

Scientists at Salk Institute develop novel platform to study kidney diseases

Grave prognosis for heart patients with treatment-resistant hypertension

Researchers generate three-dimensional kidney structures from human stem cells

Patients who undergo gastric bypass less likely to have risk of heart attack and stroke

MGH investigators identify molecule that plays key role in the breakdown of kidney filter

Satellite Healthcare, NKF partner to sponsor free Community Kidney Disease Symposium

OPKO Health completes patient enrollment in first phase 3 trial of Rayaldy for SHPT treatment

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News